Roche Buys 89bio: A $3.5B Biotech Bet

Markets & Money Today | 2 Min News | The Daily News Now! - A podcast by The Daily News Now! - Thursdays

Categories:

Business

Roche buys 89bio for $2.4B in major pharma deal! The acquisition aims to boost Roche's pipeline of liver disease treatments and offset revenue losses from expiring patents. Will this acquisition accelerate new medicines and ensure Roche's growth? Hosted on Acast. See acast.com/privacy for more information.